43,2 %Among 294 Nigerian women with breast cancer who had immunohistochemical analysis, 43.2% were classified as hormone receptor positive (HRP).
Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 9 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
381 evidences · page 8 / 16
43,2 %Among 294 Nigerian women with breast cancer who had immunohistochemical analysis, 43.2% were classified as hormone receptor positive (HRP).
Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 9 observations
13 cancersOf 15 biopsy-confirmed cancers, clinical breast examination detected an ipsilateral breast abnormality in 13 (87%) women.
Nigeriacancer du seinpublié 2022The Lancet. Global healthPubMeddocument de 19 observations
761 patientsThe total number of patients with breast cancer at the University College Hospital Ibadan, Nigeria from 2008 to 2012 was 761.
Nigeriacancer du seinobservé 2008 to 2012publié 2019The Pan African medical journalPubMeddocument de 7 observations
60 %Sleep disturbances were reported by 60% of breast cancer patients undergoing chemotherapy in Delta State, Nigeria.
Nigeriacancer du sein · sleep disturbancespublié 2026The Pan African medical journalPubMeddocument de 5 observations
70 %More than 70% of the 45 breast cancer patients assessed between January and June 2018 were well nourished.
Nigeriacancer du seinobservé January and June 2018publié 2022Nutrition and cancerPubMeddocument de 7 observations
17 %17% of the tumors were human epidermal growth factor receptor 2 (HER2)-positive.
Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873
27 %27% of the tumors were basal-like.
Nigeriacancer du seinpublié 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 12 observationsDOI 10.1200/jco.2008.19.6873
80 %In Nigeria, the incidence of breast cancer has increased by over 80% in the last four decades.
Nigeriacancer du seinobservé last four decadespublié 2022The Pan African medical journalPubMeddocument de 9 observations
Black women of African ancestry experience higher mortality rates from breast cancer than White women of European ancestry.
Nigeriacancer du seinpublié 2020Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatieurope_pmcdocument de 2 observationsDOI 10.1101/2020.10.28.359240
9,8 %Eight (9.8%) of the breast cancer patients were seen during the third year of follow-up.
Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations
The incidence of breast cancer is rising in Nigeria.
Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 9 observations
46,86 %The left breast was more commonly affected (46.86%) than the right breast (44.41%) or bilateral lesions (7.20%) among the 3,263 breast histopathology records.
Nigeriacancer du seinobservé 2015 to 2023publié 2025Scientific reportsPubMeddocument de 12 observations
31 out_of_56The median knowledge score of health care providers on breast cancer was 31 out of 56.
Nigeriacancer du seinpublié 2020JCO global oncologyPubMeddocument de 7 observations
28 %Breast cancer was an underlying aetiology in 28% of patients in the series.
Nigeriacancer du sein · pathological nipple dischargeobservé 2010-2020publié 2023West African journal of medicinePubMeddocument de 10 observations
49 yearsThe mean age of respondents was 49 years in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.
Nigeriacancer du seinobservé 2018publié 2019Journal of global oncologyPubMeddocument de 9 observations
27,9 %In the MEND case-control study, 27.9% of Nigerian breast cancer cases were grade 3.
Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations
0,51 odds_ratioWomen in the higher leisure-time physical activity quartiles (Q3–Q4) versus Q1 had lower odds of having breast cancer (OR = 0.51, 95% CI: 0.35–0.74).
Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 9 observations
58 %Among breast cancer cases recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 58% of those detected clinically were assigned to palliative care.
Nigeriacancer du seinobservé 2016 to 2018publié 2025Cancer causes & control : CCCPubMeddocument de 9 observations
29,8 scoreThe pre-intervention overall symptom domain score was 29.8 ± 10.24 for the control group.
Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations
33,333 %Approximately one-third of participants were diagnosed with high-grade breast cancer.
Nigeriacancer du seinpublié 2021Annals of global healthPubMeddocument de 7 observations
60 %Nearly 60% of the 725 health care providers surveyed believed breast cancer is always deadly.
Nigeriacancer du seinpublié 2020JCO global oncologyPubMeddocument de 7 observations
4,5 %Only 4.5% of female artisans in Ibadan, Nigeria had a high level of knowledge about breast cancer.
Nigeriacancer du seinpublié 2025Women's health (London, England)PubMeddocument de 7 observations
15 %Every additional 6 months of breastfeeding over a lifetime reduced breast cancer odds by 15% in women < 50 years.
Nigeriacancer du seinpublié 2022Cancer causes & control : CCCPubMeddocument de 7 observations
11,2 %HER2/neu enriched subtype was found in 11.2% of cases.
Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations
30,1 %Her-2/neu was overexpressed in 30.1% of 107 newly diagnosed breast cancer patients.
Nigeriacancer du seinobservé 2016-04-01 to 2018-09-30publié 2019European journal of surgical oncology : the journal of the European Society of Surgical OnPubMed
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.